Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands
· Delayed Price · Currency is EUR
1.760
0.00 (0.00%)
May 13, 2025, 2:40 PM CET
Vivoryon Therapeutics Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 46 | 52 | 212 | 249 | 380 | 180 | |
| Market Cap Growth | -75.55% | -75.55% | -14.71% | -34.60% | 111.35% | 65.63% | |
| Enterprise Value | 37 | 37 | 174 | 225 | 361 | 146 | |
| Last Close Price | 1.76 | 1.99 | 8.14 | 10.32 | 19.00 | 9.01 | |
| PS Ratio | - | - | -58.61 | - | 35.34 | - | |
| PB Ratio | 5.82 | 6.58 | 8.07 | 9.39 | 22.98 | 6.86 | |
| P/TBV Ratio | 6.54 | 7.40 | 8.37 | 9.56 | 23.74 | 7.02 | |
| EV/Sales Ratio | - | - | - | - | 33.52 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Asset Turnover | - | - | - | - | 0.40 | - | |
| Quick Ratio | 6.93 | 6.93 | 9.30 | 9.35 | 3.57 | 19.95 | |
| Current Ratio | 7.20 | 7.20 | 9.37 | 9.40 | 4.01 | 21.73 | |
| Return on Equity (ROE) | -120.41% | -120.41% | -107.38% | -130.77% | -59.17% | -47.93% | |
| Return on Assets (ROA) | -62.22% | -62.22% | -57.95% | -65.10% | -29.48% | -26.47% | |
| Return on Capital (ROIC) | -76.38% | -76.38% | -68.07% | -83.81% | -36.94% | -28.75% | |
| Earnings Yield | -44.83% | -39.65% | -13.36% | -11.32% | -3.33% | -9.17% | |
| FCF Yield | -41.80% | -36.97% | -10.16% | -8.77% | -2.96% | -7.82% | |
| Buyback Yield / Dilution | -3.27% | -3.27% | -14.64% | -10.10% | -0.12% | -59.17% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.